LA JOLLA PHARMACEUTICAL CO Finite-Lived Intangible Asset, Expected Amortization, Year Two
LA JOLLA PHARMACEUTICAL CO had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $1.60 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2022-08-15
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $1.60M.
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $1.60M.
- 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $1.60M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Two |
|---|---|
| 2022-06-30 | $1.60M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.60M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.60M 10-K · filed 2022-03-09 |